{
    "organizations": [],
    "uuid": "ea70cc95062ae97606b10d6cf94d43b41d6e8be7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cspc-pharmaceutical-group-says-can/brief-cspc-pharmaceutical-group-says-cancer-drug-approved-by-china-fda-idUSFWN1RT07T",
    "ord_in_thread": 0,
    "title": "BRIEF-CSPC Pharmaceutical Group Says Cancer Drug Approved By China FDA",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 16 (Reuters) - CSPC Pharmaceutical Group Ltd :\n* “VINORELBINE TARTRATE LIPOSOME INJECTION” GRANTED CLINICAL TRIAL APPROVAL BY CHINA FOOD AND DRUG ADMINISTRATION OF PRC Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-16T17:56:00.000+03:00",
    "crawled": "2018-04-17T12:30:02.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "cspc",
        "pharmaceutical",
        "group",
        "ltd",
        "vinorelbine",
        "tartrate",
        "liposome",
        "injection",
        "granted",
        "clinical",
        "trial",
        "approval",
        "china",
        "food",
        "drug",
        "administration",
        "prc",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}